Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SCTXScribe Therapeutics, Inc.

Nasdaq · CIK 0001853921
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts150

Identity from submissions API

NameScribe Therapeutics, Inc.
CIK0001853921
TickersSCTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN822157847
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone510-454-0213
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1150 MARINA VILLAGE PKWY
ALAMEDA
CA
94501
CA
Mailing address
1150 MARINA VILLAGE PKWY
ALAMEDA
CA
94501
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

49 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001725721-26-000009 005-95831 261562356 34 33685
2026-11-12 10-Q 10-Q 0001193125-26-458503 001-43409 261547382 34 12473632 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458486 001-43409 261547321 34 402450 1 1
2026-09-02 10-Q 10-Q 0001193125-26-380191 001-43409 261354875 34 11970792 1 1
2026-09-02 8-K 8-K 2.02,9.01 0001193125-26-380184 001-43409 261354803 34 375659 1 1
2026-08-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000210 005-95831 261233655 34 19603
2026-07-30 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000902664-26-003281 005-95831 261225169 34 30701
2026-07-30 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000059478-26-000072 005-95831 261223988 34 182653
2026-07-29 4 xslF345X06/form4-07292026_110744.xml 0001231919-26-000813 23863
2026-07-29 4 xslF345X06/ownership.xml 0000947871-26-000734 10781
2026-07-29 4 xslF345X06/ownership.xml 0000947871-26-000733 12904
2026-07-29 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000732 005-95831 261219581 34 29712
2026-07-29 4 xslF345X06/form4-07292026_080745.xml 0001739090-26-000010 7182
2026-07-28 4 xslF345X06/ownership.xml 0000902664-26-003270 15322
2026-07-28 4 xslF345X06/form4-07282026_080735.xml 0002147277-26-000003 10554
2026-07-27 4 xslF345X06/form4-07282026_010709.xml 0001781292-26-000007 12068
2026-07-27 4 xslF345X06/form4-07282026_010711.xml 0002127814-26-000004 10627
2026-07-27 4 xslF345X06/form4-07282026_010758.xml 0001282930-26-000004 5574
2026-07-27 4 xslF345X06/form4-07282026_010712.xml 0002130384-26-000004 5606
2026-07-27 4 xslF345X06/form4-07282026_010701.xml 0002075052-26-000004 5620
2026-07-27 4 xslF345X06/form4-07282026_010722.xml 0002127908-26-000004 13544
2026-07-27 4 xslF345X06/ownership.xml 0000902664-26-003254 10585
2026-07-27 8-K 8-K 5.03,9.01 0001193125-26-318263 001-43409 261206619 34 220672
2026-07-27 S-8 S-8 0001193125-26-316529 333-297707 261202609 33 244801 1 1
2026-07-27 424B4 424B4 0001193125-26-316503 333-297246 261202597 33 10445010
2026-07-24 FWP FWP 0001193125-26-314757 333-297246 261198243 34 17167
2026-07-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002417 333-297246 261198325 33 1739
2026-07-23 3 3 0001193125-26-314787 4328
2026-07-23 3 xslF345X06/ownership.xml 0000947871-26-000715 8113
2026-07-23 3 xslF345X06/form3-07242026_010746.xml 0001231919-26-000795 27507
2026-07-23 3 xslF345X06/form3-07242026_010710.xml 0002147277-26-000001 8738
2026-07-23 3 xslF345X06/form3-07242026_010719.xml 0001739090-26-000008 5373
2026-07-23 3 xslF345X06/form3-07242026_010718.xml 0001282930-26-000002 11241
2026-07-23 3 xslF345X06/form3-07242026_010732.xml 0002130384-26-000002 9163
2026-07-23 3 xslF345X06/form3-07242026_010758.xml 0001781292-26-000005 15892
2026-07-23 3 xslF345X06/form3-07242026_010752.xml 0002127814-26-000002 14489
2026-07-23 3 xslF345X06/form3-07242026_010717.xml 0002075052-26-000002 10276
2026-07-23 3 xslF345X06/form3-07242026_010714.xml 0002127908-26-000002 12866
2026-07-23 3 xslF345X06/ownership.xml 0000902664-26-003226 8917
2026-07-23 S-1MEF S-1MEF 0001193125-26-314695 333-297661 261198169 33 194120 1 1
2026-07-22 CERT 8A_CERT_SCTX_0001853921.pdf 0001354457-26-000723 001-43409 261194431 34 180983
2026-07-21 8-A12B 8-A12B 0001193125-26-309199 001-43409 261187844 34 15170
2026-07-20 S-1/A S-1/A 0001193125-26-308330 333-297246 261185163 33 11865243 1 1
2026-07-10 S-1/A S-1/A 0001193125-26-300994 333-297246 261169261 33 10866742
2026-07-02 S-1 S-1 0001193125-26-294804 333-297246 261152381 33 14704552 1 1
2026-06-12 DRS/A filename1.htm 0001193125-26-269670 377-08928 261087833 33 10898372
2026-03-06 DRS/A filename1.htm 0001193125-26-096844 377-08928 26732072 33 9053418
2026-01-09 DRS filename1.htm 0001193125-26-009106 377-08928 26523927 33 11091726
2021-04-02 D xslFormDX01/primary_doc.xml 06b 0001853921-21-000001 021-394477 21799496 33 8051

Latest XBRL company facts

One latest value per concept from companyfacts (150 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 18.94M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
ffd NetFeeAmt NetFeeAmt USD 6,791.17 2026-07-24 S-8 2026-07-27 0001193125-26-316529
ffd TtlFeeAmt TtlFeeAmt USD 6,791.17 2026-07-24 S-8 2026-07-27 0001193125-26-316529
ffd TtlOfferingAmt TtlOfferingAmt USD 49.18M 2026-07-24 S-8 2026-07-27 0001193125-26-316529
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-24 S-8 2026-07-27 0001193125-26-316529
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-23 S-1MEF 2026-07-23 0001193125-26-314695
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 874,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 8.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 8.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 12.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 316.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap Assets Assets USD 187.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AssetsCurrent Assets, Current USD 178.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 174.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 174.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value USD 171.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 174.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap Cash Cash USD 100,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 172.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 174.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 172.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 159.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 18.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 18.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStocksIncludingAdditionalPaidInCapital Common Stocks, Including Additional Paid in Capital USD 120.40M 2026-07-27 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap CommonStockValue Common Stock, Value, Issued USD 36,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -33.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 38.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -2.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 37.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 37.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 200,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 3.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 25.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 12.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap Depreciation Depreciation USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380191
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5.16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -5.16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 35.34M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap GovernmentAssistanceLiabilityCurrent GovernmentAssistanceLiabilityCurrent USD 3.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -33.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 672,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -6.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -1.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -947,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 518,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 665,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap InterestExpense Interest Expense USD 875,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 875,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD -259,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap InvestmentsAndCash Investments and Cash USD 174.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap Liabilities Liabilities USD 62.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 187.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap LiabilitiesCurrent Liabilities, Current USD 37.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 140.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 42.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -24.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -33.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -33.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingExpenses Operating Expenses USD 38.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -32.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 433,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 586,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 8.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 2.03M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380191
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 4.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 4.84M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380191
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 132.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 7.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 155.50M 2026-07-17 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 47.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 42.34M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380191
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 589,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 17.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 28.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 675,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -191.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 18,144 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.882 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.846 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.045 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 249,791 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 655,999 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.37 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 7.17 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 2.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.11 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 8.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap ShortTermInvestments Short-term Investments USD 7.42M 2026-06-30 2026 Q2 10-Q 2026-09-02 0001193125-26-380191
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 125.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 37.80M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 352,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458503

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →